Amneal reports third quarter 2023 financial results

Bridgewater, n.j.--(business wire)--amneal pharmaceuticals, inc. (nyse: amrx) (“amneal” or the “company”) announced its results today for the third quarter ended september 30, 2023. “we are pleased to report strong double-digit revenue and adjusted ebitda growth for the third quarter and raise our full year guidance. the acceleration in our growth is a testament to the strong execution of our strategy, the success of our new launches and the continued diversification of our portfolio. we are on.
AMRX Ratings Summary
AMRX Quant Ranking